Hot Stocks

Hot stocks are not about hype. They emerge when powerful themes, policy shifts, and capital flows converge. InvestorPlace analysts track fast-moving market narratives, especially in technology, AI, and infrastructure, to identify stocks drawing outsized attention and explain what is really driving those moves.

UnitedHealth Group Inc (UNH) Stock Surges on Q3 Earnings Report

By William White, InvestorPlace Writer
UnitedHealth (UNH) saw its stock take off today following the release of its earnings report for the third quarter of 2017.

How Much Higher Can Netflix, Inc. Realistically Go?

By Luke Lango, InvestorPlace Senior Investment Analyst
NFLX stock is struggling to attract buyers even after blowout quarterly results. Does that mean the Netflix growth story is maxed out?

Goldman Sachs Group Inc (GS) Stock Drops Despite Q3 Earnings Beat

By William White, InvestorPlace Writer
Goldman Sachs (GS) stock took a hit on Tuesday despite reporting positive earnings per share and revenue for the third quarter.

Zimmer Biomet Holdings, Inc. (ZBH) a Sell on Lousy Earnings Growth

By Portfolio Grader
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is one of the 783 companies in the GICS Health Care sector, and a constituent of the 162 company Health Care Equipment & Supplies GICS industry group within this sector. The market value of ZBH is $24.2 billion which places it in the top decile in its industry group. The current Portfolio Grader ranking for ZBH puts it 114 among the 162 companies in this industry group, which is a below-average position; in the third quartile of the sector with a ranking of 521 among the 783 companies in the sector, and number 3,460 in the nearly 5,000 company Portfolio Grader universe.

Baxter International (BAX) a Buy on Robust Quant Score

By Portfolio Grader
Portfolio Grader currently ranks Baxter International Inc (NYSE:BAX) a Buy. The methods for fundamental and quantitative metrics used in this analytical tool, developed by Louis Navellier researches and ranks nearly 5,000 stocks each week. BAX has maintained this ranking for 10 months.

Morgan Stanley (MS) Stock Pops on Stellar Q3 Earnings

By William White, InvestorPlace Writer
Morgan Stanley (MS) stock got a boost today after reporting positive results in its earnings report for the third quarter of 2017.

Robust Quant Score Keeps Koninklijke Philips (PHG) a Buy

By Portfolio Grader
The current recommendation of Buy for Koninklijke Philips NV (NYSE:PHG) is the result of using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. PHG has maintained this ranking for 3 months.

Can the Cord Become a Stream for Walt Disney Co?

By Dana Blankenhorn, InvestorPlace Contributor
Disney is fighting the cord-cutting trend with its own streaming services, making DIS stock both a riskier and more promising investment.

Superb Analytics for Earnings Growth Make Intuitive Surgical (ISRG) a Strong Buy

By Portfolio Grader
Intuitive Surgical Inc (NASDAQ:ISRG) is ranked as a Strong Buy using Louis Navellier's methodology for investing and his Portfolio Grader stock evaluator. ISRG has maintained this ranking for 7 months.

Boston Scientific’s (BSX) Strong Quant Score Keeps it a Buy

By Portfolio Grader
Portfolio Grader currently ranks Boston Scientific (NYSE:BSX) a Buy. With exclusive fundamental and quantitative metrics developed by Louis Navellier, this analytical tool assesses nearly 5,000 stocks weekly. This represents no change from the previous week and is the same ranking BSX has had from Portfolio Grader for the last month.

Becton Dickinson & Co (BDX) a Buy on Robust Quant Score

By Portfolio Grader
Portfolio Grader currently ranks Becton Dickinson & Co (NYSE:BDX) a Buy. The methodology for fundamental and quantitative metrics used in this analytical tool, developed by Louis Navellier researches and ranks nearly 5,000 stocks each week. This represents no change from the previous week and is the same ranking BDX has had from Portfolio Grader for 5 months.

High-Level Quant Score Makes Stryker Corporation (SYK) a Strong Buy

By Portfolio Grader
As one of the 783 companies in the GICS Health Care sector Stryker Corporation (NYSE:SYK) is a constituent of the 162 company Health Care Equipment & Supplies GICS industry group within this sector. The market value of SYK is $54.9 billion which places it in the top 10% of its industry group. The stock's current Portfolio Grader score places it 14 among the 162 companies in this industry group, positioning it among the leaders; in the top decile of the sector with a ranking of 33 among the 783 companies in the sector, and number 320 in the nearly 5,000 company Portfolio Grader universe.

Earnings Momentum Hampers Danaher Corporation (DHR) Rating

By Portfolio Grader
Portfolio Grader currently ranks Danaher Corporation (NYSE:DHR) a Hold. With proprietary fundamental and quantitative metrics developed by Louis Navellier, this analytical tool assesses nearly 5,000 stocks weekly. The current Portfolio Grader recommendation on the shares has been in place for the last month.

Healthy Earnings Momentum Keeps Abbott Laboratories (ABT) a Buy

By Portfolio Grader
Portfolio Grader currently ranks Abbott Laboratories (NYSE:ABT) a Buy. Using Louis Navellier's investing system, this analytical tool assesses stocks with fundamental and quantitative metrics. This represents no change from the previous week and is the same ranking ABT has had from Portfolio Grader for the last month.

Here’s a Quick Solution to Nike Inc (NKE) Stock Troubles

By Will Ashworth, InvestorPlace Contributor
Nike growth is slowing which is putting a crimp in NKE stock. Buying Lululemon would solve Nike's growth problem

Robust Earnings Visibility Makes Banco Santander (SAN) a Buy

By Portfolio Grader
Banco Santander SA (NYSE:SAN) is one of the 772 companies in the GICS Financials sector, and a member of the 346 company Banks GICS industry group within this sector. SAN has a market value of $97.6 billion which is in the top 10% of its industry group. Currently, the stock's Portfolio Grader ranking places it 54 among the 346 companies in this industry group, placing it among the leaders; in the top quartile of the sector with a ranking of 116 among the 772 companies in the sector, and number 546 in the nearly 5,000 company Portfolio Grader universe.

Medtronic (MDT) a Sell on Falling Industry Group Rank

By Portfolio Grader
Medtronic Plc (NYSE:MDT) is one of 162 companies within the Health Care Equipment & Supplies GICS industry group, which is in turn part of the 783 company GICS Health Care sector. MDT's market value is $105.8 billion which places it in the top 10% of its industry group. The ranking for MDT by Portfolio Grader places it 97 among the 162 companies in this industry group, giving it a lower than average position; in the third quartile of the sector with a ranking of 446 among the 783 companies in the sector, and number 3,085 in the nearly 5,000 company Portfolio Grader universe.

Royal Bank of Canada’s (RY) Healthy Quant Score Makes it a Buy

By Portfolio Grader
With a $115.6 billion market value, Royal Bank of Canada (NYSE:RY) ranks in the top 10% of its industry group, Banks, and in the top decile of sector group, Financials, in market value. From the prospective of investment attractiveness, Portfolio Grader's current ranking for RY puts it 70 among the 346 companies in this industry group, giving it a well above-average position; in the top quartile of the sector with a ranking of 153 among the 772 companies in the sector, and number 711 in the nearly 5,000 company Portfolio Grader universe.

Citigroup (C) a Buy on Strong Quant Score

By Portfolio Grader
The current recommendation of Buy for Citigroup Inc (NYSE:C) is the result of using Louis Navellier's investing approach and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for 2 months.
Load More Articles